120 related articles for article (PubMed ID: 26678861)
1. Optimization of chitosan nanoparticles for colon tumors using experimental design methodology.
Jain A; Jain SK
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1917-1926. PubMed ID: 26678861
[TBL] [Abstract][Full Text] [Related]
2. In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors.
Jain A; Jain SK
Eur J Pharm Sci; 2008 Dec; 35(5):404-16. PubMed ID: 18824095
[TBL] [Abstract][Full Text] [Related]
3. Study on colon-specific 5-Fu pH-enzyme Di-dependent chitosan microspheres.
Zhao XL; Li KX; Zhao XF; Pang DH; Chen DW
Chem Pharm Bull (Tokyo); 2008 Jul; 56(7):963-8. PubMed ID: 18591810
[TBL] [Abstract][Full Text] [Related]
4. Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon.
Li P; Yang Z; Wang Y; Peng Z; Li S; Kong L; Wang Q
J Microencapsul; 2015; 32(1):40-5. PubMed ID: 25198909
[TBL] [Abstract][Full Text] [Related]
5. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
Song Q; Jia J; Niu X; Zheng C; Zhao H; Sun L; Zhang H; Wang L; Zhang Z; Zhang Y
Nanoscale; 2019 Aug; 11(34):15958-15970. PubMed ID: 31418432
[TBL] [Abstract][Full Text] [Related]
6. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer.
Jain A; Jain SK; Ganesh N; Barve J; Beg AM
Nanomedicine; 2010 Feb; 6(1):179-90. PubMed ID: 19447205
[TBL] [Abstract][Full Text] [Related]
7. Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment.
Bose A; Elyagoby A; Wong TW
Int J Pharm; 2014 Jul; 468(1-2):178-86. PubMed ID: 24709212
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
9. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
Ma Y; Fuchs AV; Boase NR; Rolfe BE; Coombes AG; Thurecht KJ
Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
[TBL] [Abstract][Full Text] [Related]
11. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
Anitha A; Deepa N; Chennazhi KP; Lakshmanan VK; Jayakumar R
Biochim Biophys Acta; 2014 Sep; 1840(9):2730-43. PubMed ID: 24946270
[TBL] [Abstract][Full Text] [Related]
13. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats.
He W; Du Q; Cao DY; Xiang B; Fan LF
Int J Pharm; 2008 Feb; 348(1-2):35-45. PubMed ID: 17697758
[TBL] [Abstract][Full Text] [Related]
14. Aptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas.
Ghasemi Z; Dinarvand R; Mottaghitalab F; Esfandyari-Manesh M; Sayari E; Atyabi F
Carbohydr Polym; 2015 May; 121():190-8. PubMed ID: 25659689
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-Coated Cinnamon/Oregano-Loaded Solid Lipid Nanoparticles to Augment 5-Fluorouracil Cytotoxicity for Colorectal Cancer: Extract Standardization, Nanoparticle Optimization, and Cytotoxicity Evaluation.
Kamel KM; Khalil IA; Rateb ME; Elgendy H; Elhawary S
J Agric Food Chem; 2017 Sep; 65(36):7966-7981. PubMed ID: 28813148
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
17. In-vitro and in-vivo studies of pectin/ethylcellulosefilm-coated pellets of 5-fluorouracil for colonic targeting.
Wei H; Qing D; De-Ying C; Bai X; Li-Fang F
J Pharm Pharmacol; 2008 Jan; 60(1):35-44. PubMed ID: 18088503
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
19. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911
[TBL] [Abstract][Full Text] [Related]
20. New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging.
Yassin AE; Alsarra IA; Alanazi FK; Al-Mohizea AM; Al-Robayan AA; Al-Obeed OA
J Drug Target; 2010 Jan; 18(1):59-66. PubMed ID: 19653868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
